Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Neutropenia 1Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Hematologic Neoplasms 1Febrile Neutropenia 1

Interventions

Rituximab 3Cyclophosphamide 3zanubrutinib 2fludarabine 2tafasitamab 1resiniferatoxin 1obinutuzumab 1duvelisib 1Vincristine 1Vancomycin 1Thiotepa 1Surveys and Questionnaires 1Radiotherapy 1Prednisone 1Prednisolone 1PTH2 protein, human 1Observation 1Neuropsychological Tests 1Methotrexate 1Magnetic Resonance Spectroscopy 1Lisaftoclax 1Interleukin-2 1Injections, Subcutaneous 1Homoharringtonine 1Glucocorticoids 1Doxorubicin 1Dexamethasone 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Lymphoma, Non-Hodgkin × Vancomycin × Clear all
NCT07478848 2026-05-22

Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas

Abramson Cancer Center at Penn Medicine

Phase 1 Not yet recruiting
14 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡